Bioanalytical Assays to Support COVID-19 Drug Development

Bioanalytical Assays to Support COVID-19 Drug Development

Contract Research

Information

Celerion, a leader in early clinical research services and clinical bioanalysis industry, is a global company with over 50 years of experience. Our unique combination of medical expertise, clinical operations experience and scientific excellence provides our customers with the confidence to make fast, accurate decisions about their drug development. Our industry-leading labs in Lincoln and Zurich provide global vaccine bioanalytical services. Celerion has a platform of COVID-19 focused bioassays for patient safety and drug development.
CelerionTranslating science into medicine, Celerion is a premier, global provider of early clinical research. We recognize that access to experts and regulatory guidance at the appropriate times of your vaccine development plan are critical for your success. We have the experience and expertise to assist with these discussions and provide guidance into crucial early clinical development as well as pivotal efficacy and safety studies. Celerion’s expertise spans a large variety of vaccines within Infectious Diseases, Oncology, and Autoimmune Diseases. Our experience includes both preventive and therapeutic vaccines across all phases and many different routes of administration, and patient populations.

Log in